| Autor: |
Ragab, Moutaz, Abouelfadl, Mohamed Hamed, Arafa, Ahmed, Marei, Mahmoud M. |
| Předmět: |
|
| Zdroj: |
Indian Journal of Public Health Research & Development; Apr2020, Vol. 11 Issue 4, p653-656, 4p |
| Abstrakt: |
Objective: Infantile Hemangiomas can result in severe functional and aesthetic disorders. Many treatment options are available for such condition. In this study, we present our center experience with intralesional steroids injection in the management of infantile hemangioma. Method: This study is a retrospective review of a cohort of 25 patients who were presented with IHs to our center from January 2014 to January 2015. A standardized set of data for each patient was recorded in a sheet including clinical history, patients’ demographic data, clinical response, side effects and follow up visits. Colored photographs were taken for each patient at the first visit, throughout the treatment course and after finishing treatment. All the cases were treated with intralesional injection of Triamcinolone acetatein dose of 0.5mg/kg/dose once every 4-6 weeks, for 6 cycles By the same operator. Results: Twenty-five patients were managed with serial injections of intralesional Triamcinolone acetate with a mean age of 11 months. The average number of sessions was 5.2 ±0.79. Eighteen (72%) out of the 25 patients showed >50% response complete response. The adverse effects recorded; two cases (8%) showed signs of infection, bleeding from the puncture site occurred in 1 case (4%), 2 cases showed subcutaneous fat atrophy (8%), 3 cases showed hypopigmentation of the skin surrounding the lesion (12%). Conclusion: Intralesional corticosteroids injection is an effective and safe modality for treating IHs; yet, we do recommend that we should use them in bulky, isolated lesions away from the face and bony prominences. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
